GENE ONLINE|News &
Opinion
Blog

LATEST
Praxis Stock Hits All-Time Low After Phase 2 Tremor Data Released
2023-03-06
Top 3 Reasons To Attend Cell and Gene Therapy Summit
2023-03-03
BioTouch Buys Ireland’s Titan Solutions To Expand International Outreach
2023-03-03
Pfizer and GSK Neck and Neck for First FDA-Approved RSV Vaccine
2023-03-03
A New Phase in Drug Development: Programming the Genome
2023-03-02
Reata’s Groundbreaking Therapy for an Ultra-rare Neuromuscular Disease Secures FDA Approval
2023-03-02
Eli Lilly Caps Insulin At $35 A Month, Widening Access For Americans
2023-03-02
Genentech Takes Biogen to Court Over Stockpiled Multiple Sclerosis Drug Royalties
2023-03-01
Investigate the Current Status of Rivaroxaban Generic Drug Application in China
2023-03-01
Pfizer’s RSV Vaccine Wins Support From FDA Advisory Panel for Use in Older Adults
2023-03-01
Fifth HIV Patient Cured After Stem Cell Transplant in Germany
2023-03-01
Merck’s Keytruda Falls Short In Two Trials
2023-03-01
Oricell Closes $45M Series B1 Financing to Expand Development of Key Products
2023-02-28
On Rare Disease Day 2023 RemeGen Highlights Its Social Responsibility and Rare Disease Advocacy
2023-02-27
GC Biopharma Signs Agreement with Catalyst Biosciences for the Acquisition of Rare Disease Pipeline in Hematology
2023-02-27
1 2 3 4 5 191
Scroll to Top